Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Archives of Neurology

• Publication date

  2003-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHNEUR.60.4.521PMID 12707065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver, by S. A. Kinnier Wilson, (From the National Hospital, and the Laboratory of the National Hospital, Queen Square, London) Brain 1912: 34; 295-509.

  2009cited by this paper
• Chronic manganese poisoning: A neuropathological study with determination of manganese distribution in the brain

  2004cited by this paper
• Persistence of mild parkinsonism 4 months after liver transplantation in patients with preoperative minimal hepatic encephalopathy: a study on neuroradiological and blood manganese changes

  2002cited by this paper
• Magnetic resonance imaging and proton spectroscopic alterations correlate with parkinsonian signs in patients with cirrhosis.

  2000cited by this paper
• Pathophysiology of the basal ganglia in Parkinson's disease.

  2000cited by this paper
• Diagnosing portal hypertension.

  2000cited by this paper
• Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction.

  1999cited by this paper
• Manganese intoxication during total parenteral nutrition: report of two cases and review of the literature.

  1999cited by this paper
• The Basal Ganglia and Portal-Systemic Encephalopathy

  1998cited by this paper
• Long-term progression in chronic manganism

  1998cited by this paper
• Acquired hepatocerebral degeneration: MR and pathologic findings.

  1998cited by this paper
• MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation.

  1997cited by this paper
• Expedited Publication

  1996cited by this paper
• Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis.

  1996cited by this paper
• Increased blood manganese in cirrhotic patients: Relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms

  1996cited by this paper
• Liver dysfunction and probable manganese accumulation in the brainstem and basal ganglia.

  1995cited by this paper
• Aminopyrine breath test improves long-term prognostic evaluation in patients with alcoholic cirrhosis in Child classes A and B.

  1995cited by this paper
• MRI and PET studies of manganese‐intoxicated monkeys

  1995cited by this paper
• Pallidal lesions in patients with liver cirrhosis: clinical and MRI evaluation

  1995cited by this paper
• Manganese and chronic hepatic encephalopathy.

  1995cited by this paper
• MR imaging of the basal ganglia in chronic liver disease: correlation of T1-weighted and magnetisation transfer contrast measurements with liver dysfunction and neuropsychiatric status

  1995cited by this paper
• Increased signals seen in globus pallidus in T1‐weighted magnetic resonance imaging in cirrhotics are not suggestive of chronic hepatic encephalopathy

  1995cited by this paper
• Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy

  1995cited by this paper
• Increased manganese concentrations in pallidum of cirrhotic patients.

  1995cited by this paper
• Brain magnetic resonance imaging in non-alcoholic cirrhosis.

  1995cited by this paper
• Chronic acquired hepatocerebral degeneration: Case reports and new insights

  1995cited by this paper
• Accumulation of manganese and copper in pallidum of cirrhotic patients: role in the pathogenesis of hepatic encephalopathy?

  1995cited by this paper
• Manganese intoxication and chronic liver failure

  1994cited by this paper
• Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy

  1994cited by this paper
• Manganism and idiopathic parkinsonism

  1994cited by this paper
• Increased activities of MAOA and MAOB in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.

  1993cited by this paper
• Selective loss of pallidal dopamine D2 receptor density in hepatic encephalopathy.

  1993cited by this paper
• Manganese encephalopathy: utility of early magnetic resonance imaging.

  1993cited by this paper
• Progression after chronic manganese exposure

  1993cited by this paper
• Hyperintense globus pallidus on T1‐weighted MRI in cirrhotic patients is associated with severity of liver failure

  1993cited by this paper
• Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy.

  1992cited by this paper
• Basal ganglial signal intensity alterations: reversal after discontinuation of parenteral manganese administration.

  1992cited by this paper
• Pallidal hyperintensity on magnetic resonance imaging in cirrhotic patients: Clinical correlations

  1992cited by this paper
• Manganese intoxication during total parenteral nutrition.

  1992cited by this paper
• Altered Cerebral Blood Flow and Glucose Metabolism in Patients with Liver Disease and Minimal Encephalopathy

  1991cited by this paper
• Chronic acquired hepatic failure: MR imaging of the brain at 1.5 T.

  1991cited by this paper
• Hyperintense basal ganglia on T1-weighted MR images in patients receiving parenteral nutrition.

  1991cited by this paper
• MR imaging of acquired hepatocerebral degeneration.

  1991cited by this paper
• Globus pallidus alterations and brain atrophy in liver cirrhosis patients with encephalopathy: an MR imaging study.

  1991cited by this paper
• Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images.

  1991cited by this paper
• Hyperintensity in the globus pallidus on T1‐weighted and inversion‐recovery MRI

  1991cited by this paper
• Movement disorders in alcoholism

  1990cited by this paper
• Neuropsychological deficits and morphological MRI brain scan abnormalities in apparently healthy non-encephalopathic patients with cirrhosis. A controlled study.

  1989cited by this paper
• Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy

  1989cited by this paper
• Aromatic and branched-chain amino acids in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy

  1989cited by this paper
• Visualizing manganese in the primate basal ganglia with magnetic resonance imaging.

  1989cited by this paper
• Chronic manganese intoxication.

  1989cited by this paper
• Acquired hepatocerebral degeneration: MR similarity with Wilson disease.

  1988cited by this paper
• Clinical and statistical validity of conventional prognostic factors in predicting short‐term survival among cirrhotics

  1987cited by this paper
• Cerebral morphological abnormalities associated with non-alcoholic cirrhosis.

  1986cited by this paper
• Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C. Cotzias).

  1984cited by this paper
• The effect of manganese inhalation on basal ganglia dopamine concentrations in rhesus monkey.

  1984cited by this paper
• [Chronic hepatic encephalopathies. Acquired cerebral degeneration not due to Wilson's disease].

  1983cited by this paper
• Distribution of cerebral lesions in acquired hepatocerebral degeneration.

  1981cited by this paper
• Determination of manganese in whole blood and serum.

  1980cited by this paper
• Determination of manganese in whole blood and serum.

  1980cited by this paper
• Chronic manganese intoxication.

  1974cited by this paper
• Assessment of aminopyrine metabolism in man by breath analysis after oral administration of 14C-aminopyrine. Effects of phenobarbital, disulfiram and portal cirrhosis.

  1974cited by this paper
• Transection of the oesophagus for bleeding oesophageal varices

  1973cited by this paper
• Choreoathetosis in porto-systemic encephalopathy.

  1967cited by this paper
• Chronic manganese poisoning

  1967cited by this paper
• THE ACQUIRED (NON-WILSONIAN) TYPE OF CHRONIC HEPATOCEREBRAL DEGENERATION

  1965cited by this paper
• HEPATOCEREBRAL DEGENERATION, A SPECIAL TYPE

  1952influential reference
• WILSON'S DISEASE IN THE LIGHT OF CEREBRAL CHANGES FOLLOWING ORDINARY ACQUIRED LIVER DISORDERS

  1942influential reference
• Histopathologische Untersuchungen zur Frage der Beziehung zwischen Leber- und Gehirnveränderungen

  1935influential reference
• PROGRESSIVE LENTICULAR DEGENERATION : A FAMILIAL NERVOUS DISEASE ASSOCIATED WITH CIRRHOSIS OF THE LIVER.

  1912influential reference

• Rifaximin's therapeutic spectrum: approved indications and experimental insights into emerging uses.

  2026cites this paper
• Liver fibrosis associated with more severe motor deficits in early Parkinson's disease.

  2025cites this paper
• The role of presynaptic dopaminergic imaging in acquired neurological conditions affecting basal ganglia: a systematic review

  2025influential citation
• Parkinson's disease and metabolic disorders, understanding their shared co-morbidity through the autonomic nervous system.

  2025cites this paper
• The gut–brain axis underlying hepatic encephalopathy in liver cirrhosis

  2025cites this paper
• The Intricate Interplay: Microbial Metabolites and the Gut‐Liver‐Brain Axis in Parkinson's Disease

  2025cites this paper
• Síntomas neuropsiquiátricos en un paciente con cirrosis: más allá de la encefalopatía hepática

  2024cites this paper
• Partial Reversal of Shunt Myelopathy and Hepatic Parkinsonism Using Balloon-Occluded Retrograde Transvenous Obliteration

  2024cites this paper
• Navigating Diagnostic Challenges: A Case of Acquired Hepatocerebral Degeneration Presenting as Worsening Hepatic Encephalopathy in Chronic Liver Disease

  2024cites this paper
• Gut microbiome-brain-cirrhosis axis.

  2023cites this paper
• Spectrum of movement disorders in liver disease: A case series

  2023cites this paper
• Manganeso asociado con degeneración hepatolenticular no wilsoniana como causa infrecuente de encefalopatía: reporte de caso

  2023cites this paper
• Reactive astrocytes targeting with oral vitamin A: Efficient neuronal regeneration for Parkinson's disease treatment and reversal of associated liver fibrosis

  2023cites this paper
• Acquired Parkinson’s Disease in Alcoholic Cirrhosis: The Rarest Association

  2023cites this paper
• Blood and urine manganese exposure in non-alcoholic fatty liver disease and advanced liver fibrosis: an observational study

  2022cites this paper
• Hepatic encephalopathy and its management

  2022cites this paper
• Acquired Hepatocerebral Degeneration After a Splenorenal Shunt in the Sub-Saharan Africa Context: A Case Report and Brief Review of Literature

  2022cites this paper
• Hepatic encephalopathy: modern aspects of diagnosis and treatment

  2021cites this paper
• Atypical parkinsonism, parkinsonism-plus syndromes and secondary parkinsonian disorders

  2021cites this paper
• GWAS of serum ALT and AST reveals an association of SLC30A10 Thr95Ile with hypermanganesemia symptoms

  2021cites this paper
• Role of excretion in manganese homeostasis and neurotoxicity: A historical perspective.

  2021cites this paper
• Chronic acquired hepatocerebral degeneration presenting with Meige’s syndrome and behavioral symptoms fully reversed by liver transplantation

  2021cites this paper
• Movement Disorders Associated With General Medical Diseases

  2021cites this paper
• Up-regulation of the manganese transporter SLC30A10 by hypoxia-inducible factors defines a homeostatic response to manganese toxicity

  2021cites this paper
• Manganese Toxicity Associated With Total Parenteral Nutrition: A Review

  2021cites this paper
• Movement Disorders and Liver Disease

  2021cites this paper
• Alcohol and the Nervous System

  2021cites this paper
• Hepatic and Pancreatic Encephalopathy

  2021cites this paper
• [New approaches to the pathogenesis, clinic, and treatment of hepatic encephalopathy].

  2021cites this paper
• Does Manganese Contribute to Methamphetamine-Induced Psychosis?

  2020cites this paper
• Acquired hepatocerebral degeneration and hepatic encephalopathy: one or two entities?

  2020cites this paper
• Hepatic Encephalopathy

  2020cites this paper
• Pathophysiology of Hepatic Encephalopathy.

  2020cites this paper
• Maintaining Translational Relevance in Animal Models of Manganese Neurotoxicity.

  2020cites this paper
• Genome-wide association study of circulating liver enzymes reveals an expanded role for manganese transporter SLC30A10 in liver health

  2020cites this paper
• Gut microbiome dysbiosis is associated with elevated toxic bile acids in Parkinson’s disease

  2020cites this paper
• A Prospective Study of the Prevalence of Parkinsonism in Patients With Liver Cirrhosis

  2020cites this paper
• Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and Neurodegeneration

  2020cites this paper
• Evaluate the adverse impact of metal oxide on workers of different age groups that engage with gas metal arc welding process: health risk assessment

  2020cites this paper
• Hypermanganesemia-Induced Cerebral Toxicity Mimicking an Acute Ischemic Stroke: A Case Report and Review of Overlapping Pathologies

  2020cites this paper
• Pathophysiology of hepatic encephalopathy and future treatment options

  2019cites this paper
• Role of Astrocytes in Manganese Neurotoxicity Revisited

  2019cites this paper
• Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology

  2019cites this paper
• Pathophysiology of hepatic encephalopathy and future treatment options.

  2019cites this paper
• A double‐blind randomized controlled trial to assess efficacy of bromocriptine in cirrhotic patients with hepatic parkinsonism

  2019cites this paper
• How to approach a patient with parkinsonism - red flags for atypical parkinsonism.

  2019cites this paper
• Iron and manganese-related CNS toxicity: mechanisms, diagnosis and treatment

  2019influential citation
• Manganese transporter Slc30a10 controls physiological manganese excretion and toxicity.

  2019cites this paper
• Change in metabolic and cognitive state among people of the Aral zone of ecological disaster

  2018cites this paper
• Reversibility of Acquired Hepatocerebral Degeneration After Liver Transplantation

  2018cites this paper
• Diagnosis and management of hepatic encephalopathy.

  2018cites this paper
• Atypical Neuropsychiatric Presentation in a Patient Expecting Liver Transplantation

  2018cites this paper
• Zebrafish slc30a10 deficiency revealed a novel compensatory mechanism of Atp2c1 in maintaining manganese homeostasis

  2017cites this paper
• Shunt occlusion for portosystemic shunt syndrome related refractory hepatic encephalopathy—A single-center experience in 21 patients from Kerala

  2017cites this paper
• Neurological disorders in liver transplant candidates: Pathophysiology and clinical assessment.

  2017cites this paper
• Predictive models of minimal hepatic encephalopathy for cirrhotic patients based on large-scale brain intrinsic connectivity networks

  2017cites this paper
• Recent Updates on Acquired Hepatocerebral Degeneration

  2017influential citation
• Falls in Patients With Liver Cirrhosis.

  2017cites this paper
• 18F-FP-CIT dopamine transporter PET findings in cirrhotic patients with parkinsonism.

  2017influential citation
• Reduced TH expression and α-synuclein accumulation contribute towards nigrostriatal dysfunction in experimental hepatic encephalopathy

  2017cites this paper
• Investigation of manganese homeostasis in dogs with anaemia and chronic enteropathy

  2017cites this paper
• The Pallidal Index in Patients with Acute-on-Chronic Liver Disease: Is It a Predictor of Severe Hepatic Encephalopathy?

  2017cites this paper
• Falls in Patients With Liver Cirrhosis.

  2017cites this paper
• A Study of Extrapyramidal Manifestations Accompanying Decompensated Viral Hepatic Cirrhosis Patients.

  2017cites this paper
• Parkinsonism and high-intensity midbrain lesions on T2-weighted imaging in hepatic encephalopathy: a case report

  2017cites this paper
• A rare case of acquired hepatocerebral degeneration in cirrhosis

  2017influential citation
• Ototoxicity of Divalent Metals

  2016cites this paper
• Complete title : Parkinsonian Syndrome and Ataxia as a Presenting Finding of Acquired Hepatocerebral Degeneration

  2016cites this paper
• Non-Wilsonian hepatolenticular degeneration: Clinical and MRI observations in four families from south India.

  2016cites this paper
• Movement Disorders in Non-Wilsonian Hepatic Cirrhotic Patients: The Subgroup Analysis of Various Phenotypes and Associated Risk Factors

  2016cites this paper
• Neurologic Manifestations of Systemic Disease ( N Scolding and C Rice , Section Editors ) Management of Neurologic Manifestations in Patients with Liver Disease

  2016cites this paper
• Neurological examination

  2016cites this paper
• Acquired Hepato Cerebral Degeneration An Atypical Finding in MRI of Brain mimicking Bilateral Ischaemic Stroke

  2016cites this paper
• Plantar pressure distribution patterns during gait in patients with liver cirrhosis

  2016cites this paper
• Chapter 81 – Neuropsychiatric Complications

  2015cites this paper
• Hemodialysis-related portal-systemic encephalopathy.

  2015cites this paper
• Manganese Is Essential for Neuronal Health.

  2015cites this paper
• The Whole Spectrum of Alcohol-Related Changes in the CNS: Practical MR and CT Imaging Guidelines for Daily Clinical Use

  2015cites this paper
• Diplopia and Ptosis as the Initial Manifestations of Acquired Hepatocerebral Degeneration

  2015cites this paper
• Manganese Encephalopathy among Ephedron Abusers‐Case Reports

  2015cites this paper
• Pathogenesis of hepatic encephalopathy in cirrhosis: the concept of synergism revisited

  2015cites this paper
• Manganese-Induced Parkinsonism Is Not Idiopathic Parkinson's Disease: Environmental and Genetic Evidence.

  2015cites this paper
• Mechanisms of Heavy Metal Neurotoxicity: Lead and Manganese

  2015cites this paper
• Etiology of cirrhosis predicts deterioration of “brain reserve” after hepatic encephalopathy or transjugular intrahepatic portosystemic shunt

  2015cites this paper
• Movement disorders in systemic diseases.

  2015cites this paper
• Reprint of: Nutrition in the Management of Cirrhosis and its Neurological Complications.

  2015cites this paper
• Role of dopaminergic and serotonergic neurotransmitters in behavioral alterations observed in rodent model of hepatic encephalopathy.

  2015cites this paper
• Identification of dopaminergic neurons of the substantia nigra pars compacta as a target of manganese accumulation.

  2015cites this paper
• Neurologic Manifestations of Chronic Liver Disease and Liver Cirrhosis.

  2015cites this paper
• Movement Disorders in Non-Wilsonian Cirrhotic Patients: A Report of the Prevalence and Risk Factors from a Study Done in a Medical School in an Agricultural-Based Community

  2015cites this paper
• Challenges in Diagnosing Hepatic Encephalopathy

  2014cites this paper
• Nutrition in the management of cirrhosis and its neurological complications.

  2014cites this paper
• Hepatic encephalopathy in alcoholic cirrhosis.

  2014cites this paper
• Puzzles in Practice

  2014cites this paper
• Acute stroke-like presentation of acquired hepatocerebral degeneration

  2014cites this paper
• Manganism in the 21st century: the Hanninen lecture.

  2014cites this paper
• Portosystemic encephalopathy.

  2014cites this paper
• Wykładniki ciśnienia tętniczego w chorobach zwyrodnieniowych układu nerwowego

  2014cites this paper
• Chronic Liver Disease, Cirrhosis and Complications: Part 2: Hepatic Encephalopathy and Other Systemic Effects

  2014cites this paper
• SLC30A10 Is a Cell Surface-Localized Manganese Efflux Transporter, and Parkinsonism-Causing Mutations Block Its Intracellular Trafficking and Efflux Activity

  2014cites this paper